📈 Berkshire Hathaway Stock: Price, Trends, and What’s Next
As of February 10, 2026, Berkshire Hathaway Inc. Class B (BRK.B) trades at $498.08 on the NYSE. Mark your calendar: February 27, 2026 is absolutely critical – that’s when Berkshire releases its Q4 2025 earnings report. Historically, these reports can shift prices dramatically within hours.
How Earnings Reports Move BRK.B Stock
| Date | Event | Pre-News Price | Post-News Change |
|---|---|---|---|
| Aug 2, 2025 | Q2 2025 Earnings | ~$495 | +2.1% (beat estimates by $0.13) |
| May 3, 2025 | Q1 2025 Earnings | ~$505 | -1.8% (missed estimates by $0.25) |
| Feb 22, 2025 | Q4 2024 Earnings | ~$475 | +8.2% (massive beat by $2.30) |
| Nov 1, 2025 | Q3 2025 Earnings | ~$490 | +3.5% (strong operating results) |
| Aug 3, 2024 | Q2 2024 Earnings | ~$460 | +4.7% (insurance gains) |
| May 4, 2024 | Q1 2024 Earnings | ~$445 | +2.3% (steady growth) |
Trend Insight: Positive surprises like the February 2025 report can trigger explosive moves upward. Negative results cause short-term dips, but Berkshire’s fundamental strength typically brings recovery within weeks.
6-Month Price Journey (August 2025 – February 2026)
Berkshire shares experienced a rollercoaster ride over the past six months:
- August 2025: Trading around $502 after Q2 earnings beat
- October 2025: Dipped to $480 range amid market uncertainty
- December 2025: Recovered to $502.65 monthly close
- January 2026: Pulled back to $480.53 monthly close
- February 2026: Currently at $498.08 with recent volatility
The stock has traded in a $480 to $520 range throughout this period, showing remarkable stability despite leadership transition news. This represents about a 4% decline from December highs to current levels.
Why the volatility?
- Leadership transition uncertainty with Warren Buffett stepping down
- Market digestion of the massive $9.7 billion OxyChem acquisition
- Broader economic concerns affecting Berkshire’s diverse portfolio
🔮 Price Forecast: 2026-2030
2026 Forecast: Average target $517-550 with potential spikes to $591 mid-year (Long Forecast). The OxyChem integration and first full year under Greg Abel will be key drivers.
2028 Forecast: Projected average $827 with range of $806-$860 (CoinCodex). This assumes successful leadership transition and continued capital deployment.
2030 Forecast: While specific targets are limited, extrapolating growth suggests $900-$1,100 range based on historical compounding and Berkshire’s massive cash position.
Verdict: BUY for long-term investors. Short-term traders should wait for post-earnings opportunities around February 27.
⚠️ Key Risks vs. Positive Signals
Risks to Consider
- Leadership Transition Risk: First year without Warren Buffett as CEO creates uncertainty
- Size Limitations: At $1+ trillion market cap, finding meaningful acquisitions is increasingly difficult
- Economic Sensitivity: Insurance and industrial segments vulnerable to recession
- Interest Rate Exposure: Massive cash position ($167+ billion) affected by rate changes
- Regulatory Changes: Potential impacts across insurance, rail, and energy businesses
Green Lights for 2026
- Major Acquisition: The $9.7 billion OxyChem deal adds stable chemical cash flows (Manufacturing Dive)
- Continuity Strategy: Greg Abel has managed non-insurance operations since 2018
- Buffett’s Ongoing Role: Remains as chairman and continues daily office presence
- Massive Cash War Chest: Over $167 billion available for opportunities
- Diversified Protection: Insurance float provides stability during market turbulence
🛡️ What Should a Beginner Trader Do Today?
- Start Small: Begin with fractional shares if the $500 price seems steep
- Use Dollar-Cost Averaging: Invest fixed amounts weekly/monthly to smooth entry points
- Set Earnings Alerts: Monitor around February 27 for potential buying opportunities
- Allocate Wisely: Limit Berkshire to 10-15% of a diversified portfolio
- Think Long-Term: This isn’t a quick trade – it’s a multi-year commitment
Humorous take: “Trading BRK.B without understanding Buffett’s philosophy is like trying to cook without tasting – you might get something edible, but it won’t be the masterpiece you hoped for.”
✅ How to Buy Berkshire Hathaway Inc. (BRK.B) Shares – Step by Step
| Step | Action | Why It Matters |
|---|---|---|
| 1 | Choose Your Platform | Ensure it offers NYSE-listed US stocks and fractional shares |
| 2 | Complete Account Setup | Provide identification and funding details (typically 1-3 business days) |
| 3 | Fund Your Account | Start with an amount you’re comfortable risking – even $50 works for fractional shares |
| 4 | Search “BRK.B” | Use the exact ticker symbol, not just “Berkshire Hathaway” |
| 5 | Select Order Type | Use limit orders to control your entry price; avoid market orders during volatility |
| 6 | Review Fees | Look for platforms with low or zero commission on stock trades |
| 7 | Confirm Purchase | Double-check quantity and price before finalizing |
| 8 | Set Price Alerts | Monitor your investment without constant checking |
| 9 | Plan Your Exit Strategy | Decide in advance when you’ll take profits or cut losses |
| 10 | Track Performance | Use portfolio tracking tools to monitor your investment |
💡 Why Exness Fits New Investors
Exness simplifies stock access for beginners with features perfectly suited for those starting their investment journey:
- Minimum deposit just $5 – Test strategies with minimal risk before committing larger amounts
- 1-minute KYC process – Upload any single ID document and start trading almost instantly
- 100+ withdrawal methods – Flexibility with crypto, e-wallets, bank cards, and local payment options
- Fractional shares available – Own pieces of expensive stocks like BRK.B without needing full share prices
- Educational resources – Access the Exness blog for continuous learning and market insights
🌍 Berkshire Hathaway in 2026: The Post-Buffett Era Begins
Berkshire Hathaway dominates as a $1+ trillion conglomerate spanning insurance (Geico), railroads (BNSF), energy (MidAmerican), consumer brands (See’s Candies), and now chemicals through OxyChem. The company’s decentralized model allows each business to operate independently while benefiting from Berkshire’s financial strength.
Current Market Position: Trading at approximately 16x earnings with a price-to-book ratio around 1.54, representing fair valuation relative to historical levels. The stock has struggled to outperform the S&P 500 in recent years due to its massive size, but remains a bedrock holding for value investors worldwide.
Interesting Fact from 2025: In what may be Warren Buffett’s final major acquisition as CEO, Berkshire secured OxyChem for $9.7 billion after just a 90-minute meeting with Occidental Petroleum executives (Fortune). The deal adds chemical plants across 10 U.S. states plus Canada and Chile, generating over $1 billion in annual pretax income.
